ERBB2 and neoplasm: First, HER2+ BCs have higher stromal tumor-infiltrating lymphocytes (TILs) levels in general than hormone receptor positive (HR+)/HER2- BCs, implying that HER2+ disease is usually more immunogenic [7, 8].